Herediter neuromuscularis betegségek szûrése molekuláris genetikai módszerekkel hazai Roma populációban.

Translated title of the contribution: Screening for hereditary neuromuscular disorders with molecular genetic methods in the Roma population of Hungary

Herczegfalvi Agnes, Pikó Henriett, V. Karcagi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Recent medical genetic research has identified a number of novel, or previously known, but rare conditions, caused by private founder mutations. The Finnish and Ashkenazi Jew populations provide the best examples for identifying genes in unique genetic disorders. In these populations, research efforts and high-level medical services resulted in intense improvements of medical care and in organization of population-based screening programs. Hereditary disorders of the Roma populations are known for a long time. The genetic background of these diseases has been established by extensive molecular genetic studies. The Romas represent 6% of the Hungarian population and live under extremely bad health conditions. Therefore, our aim was to map the incidence of the hereditary neuromuscular disorders among the Hungarian Roma population. Moreover, we intended to provide proper information, genetic counseling and possible prevention strategies for the families at risk, which should represent a primer task in public health. Because of our experience in neuromuscular disorders, we choose six, frequent, autosomal recessive disorders for these clinical and genetic studies: hereditary motor and sensory neuropathy type Lom (HMSNL), hereditary motor and sensory neuropathy type Russe (HMSNR), congenital cataracts facial dysmorphism syndrome (CCFDN), limb-girdle muscular dystrophy 2C (LGMD2C), congenital myasthenic syndrome (CMS) and spinal muscular atrophy (SMA). Following identification of the founder mutations, the possibility of prenatal diagnosis and carrier screening for family members will contribute to the decrease of the recurrence risk for these severe, mostly untreatable disorders.

Original languageHungarian
Pages (from-to)426-430
Number of pages5
JournalIdeggyógyászati szemle
Volume61
Issue number11-12
Publication statusPublished - Nov 30 2008

Fingerprint

Roma
Hungary
Molecular Biology
Inborn Genetic Diseases
Population
Congenital Myasthenic Syndromes
Hereditary Sensory and Motor Neuropathy
Limb-Girdle Muscular Dystrophies
Spinal Muscular Atrophy
Jews
Genetic Research
Mutation
Genetic Counseling
Medical Genetics
Prenatal Diagnosis
Cataract
Biomedical Research
Public Health
Organizations
Recurrence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Herediter neuromuscularis betegségek szûrése molekuláris genetikai módszerekkel hazai Roma populációban. / Agnes, Herczegfalvi; Henriett, Pikó; Karcagi, V.

In: Ideggyógyászati szemle, Vol. 61, No. 11-12, 30.11.2008, p. 426-430.

Research output: Contribution to journalArticle

@article{0a66bf6d1ab745f38ea4b86548b6008d,
title = "Herediter neuromuscularis betegs{\'e}gek sz{\^u}r{\'e}se molekul{\'a}ris genetikai m{\'o}dszerekkel hazai Roma popul{\'a}ci{\'o}ban.",
abstract = "Recent medical genetic research has identified a number of novel, or previously known, but rare conditions, caused by private founder mutations. The Finnish and Ashkenazi Jew populations provide the best examples for identifying genes in unique genetic disorders. In these populations, research efforts and high-level medical services resulted in intense improvements of medical care and in organization of population-based screening programs. Hereditary disorders of the Roma populations are known for a long time. The genetic background of these diseases has been established by extensive molecular genetic studies. The Romas represent 6{\%} of the Hungarian population and live under extremely bad health conditions. Therefore, our aim was to map the incidence of the hereditary neuromuscular disorders among the Hungarian Roma population. Moreover, we intended to provide proper information, genetic counseling and possible prevention strategies for the families at risk, which should represent a primer task in public health. Because of our experience in neuromuscular disorders, we choose six, frequent, autosomal recessive disorders for these clinical and genetic studies: hereditary motor and sensory neuropathy type Lom (HMSNL), hereditary motor and sensory neuropathy type Russe (HMSNR), congenital cataracts facial dysmorphism syndrome (CCFDN), limb-girdle muscular dystrophy 2C (LGMD2C), congenital myasthenic syndrome (CMS) and spinal muscular atrophy (SMA). Following identification of the founder mutations, the possibility of prenatal diagnosis and carrier screening for family members will contribute to the decrease of the recurrence risk for these severe, mostly untreatable disorders.",
author = "Herczegfalvi Agnes and Pik{\'o} Henriett and V. Karcagi",
year = "2008",
month = "11",
day = "30",
language = "Hungarian",
volume = "61",
pages = "426--430",
journal = "Ideggyogyaszati Szemle",
issn = "0019-1442",
publisher = "Ifjusagi Lap-es Konyvkiado Vallalat",
number = "11-12",

}

TY - JOUR

T1 - Herediter neuromuscularis betegségek szûrése molekuláris genetikai módszerekkel hazai Roma populációban.

AU - Agnes, Herczegfalvi

AU - Henriett, Pikó

AU - Karcagi, V.

PY - 2008/11/30

Y1 - 2008/11/30

N2 - Recent medical genetic research has identified a number of novel, or previously known, but rare conditions, caused by private founder mutations. The Finnish and Ashkenazi Jew populations provide the best examples for identifying genes in unique genetic disorders. In these populations, research efforts and high-level medical services resulted in intense improvements of medical care and in organization of population-based screening programs. Hereditary disorders of the Roma populations are known for a long time. The genetic background of these diseases has been established by extensive molecular genetic studies. The Romas represent 6% of the Hungarian population and live under extremely bad health conditions. Therefore, our aim was to map the incidence of the hereditary neuromuscular disorders among the Hungarian Roma population. Moreover, we intended to provide proper information, genetic counseling and possible prevention strategies for the families at risk, which should represent a primer task in public health. Because of our experience in neuromuscular disorders, we choose six, frequent, autosomal recessive disorders for these clinical and genetic studies: hereditary motor and sensory neuropathy type Lom (HMSNL), hereditary motor and sensory neuropathy type Russe (HMSNR), congenital cataracts facial dysmorphism syndrome (CCFDN), limb-girdle muscular dystrophy 2C (LGMD2C), congenital myasthenic syndrome (CMS) and spinal muscular atrophy (SMA). Following identification of the founder mutations, the possibility of prenatal diagnosis and carrier screening for family members will contribute to the decrease of the recurrence risk for these severe, mostly untreatable disorders.

AB - Recent medical genetic research has identified a number of novel, or previously known, but rare conditions, caused by private founder mutations. The Finnish and Ashkenazi Jew populations provide the best examples for identifying genes in unique genetic disorders. In these populations, research efforts and high-level medical services resulted in intense improvements of medical care and in organization of population-based screening programs. Hereditary disorders of the Roma populations are known for a long time. The genetic background of these diseases has been established by extensive molecular genetic studies. The Romas represent 6% of the Hungarian population and live under extremely bad health conditions. Therefore, our aim was to map the incidence of the hereditary neuromuscular disorders among the Hungarian Roma population. Moreover, we intended to provide proper information, genetic counseling and possible prevention strategies for the families at risk, which should represent a primer task in public health. Because of our experience in neuromuscular disorders, we choose six, frequent, autosomal recessive disorders for these clinical and genetic studies: hereditary motor and sensory neuropathy type Lom (HMSNL), hereditary motor and sensory neuropathy type Russe (HMSNR), congenital cataracts facial dysmorphism syndrome (CCFDN), limb-girdle muscular dystrophy 2C (LGMD2C), congenital myasthenic syndrome (CMS) and spinal muscular atrophy (SMA). Following identification of the founder mutations, the possibility of prenatal diagnosis and carrier screening for family members will contribute to the decrease of the recurrence risk for these severe, mostly untreatable disorders.

UR - http://www.scopus.com/inward/record.url?scp=58149331866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149331866&partnerID=8YFLogxK

M3 - Article

VL - 61

SP - 426

EP - 430

JO - Ideggyogyaszati Szemle

JF - Ideggyogyaszati Szemle

SN - 0019-1442

IS - 11-12

ER -